The Citalopram for Agitation in Alzheimer Disease Study ( CitAD ) was a randomized , placebo-controlled , double-blind , parallel group trial that enrolled 186 patients with probable Alzheimer disease and clinically significant agitation from 8 academic centers in the United States and Canada from August 2009 to January 2013 .